Zoledronic acid for chronic kidney disease–associated osteoporosis
This case highlights the potential role of bisphosphonates in chronic kidney disease-associated osteoporosis and the need for trials to establish the safety and efficacy of anti-resorptive drugs in this patient population.
Authors
- Henrik L. Jørgensen (ORCID: https://orcid.org/0000-0001-6374-761X)
- S. Sakthivel
- Krista Dybtved Kjærgaard
- Bente Langdahl
- Per Ivarsen
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Archives of Osteoporosis
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1007/s11657-026-01680-2
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00